Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Tryptophan Metabolism as a Pharmacological Target
Morgane Modoux, Nathalie Rolhion, Sridhar Mani, et al.
Trends in Pharmacological Sciences (2020) Vol. 42, Iss. 1, pp. 60-73
Open Access | Times Cited: 223

Showing 1-25 of 223 citing articles:

Tryptophan metabolism in health and disease
Xue Chen, Ganglei Li, Qiuxian Zheng, et al.
Cell Metabolism (2023) Vol. 35, Iss. 8, pp. 1304-1326
Open Access | Times Cited: 338
Functions of Gut Microbiota Metabolites, Current Status and Future Perspectives
Juan Liu, Yuzhu Tan, Hao Cheng, et al.
Aging and Disease (2022) Vol. 13, Iss. 4, pp. 1106-1106
Open Access | Times Cited: 249
Tryptophan Metabolism in Depression: A Narrative Review with a Focus on Serotonin and Kynurenine Pathways
Ana Salomé Correia, Nuno Vale
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 15, pp. 8493-8493
Open Access | Times Cited: 175
Dual Role of Indoles Derived From Intestinal Microbiota on Human Health
Xuewei Ye, Haiyi Li, Komal Anjum, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 125
Macrophage immunometabolism in inflammatory bowel diseases: From pathogenesis to therapy
Xiaohua Pan, Qing Zhu, Li‐Long Pan, et al.
Pharmacology & Therapeutics (2022) Vol. 238, pp. 108176-108176
Closed Access | Times Cited: 117
The Role of Tryptophan Dysmetabolism and Quinolinic Acid in Depressive and Neurodegenerative Diseases
Knut Hestad, Jan Alexander, Helge Rootwelt, et al.
Biomolecules (2022) Vol. 12, Iss. 7, pp. 998-998
Open Access | Times Cited: 101
Gut Microbiome–Brain Alliance: A Landscape View into Mental and Gastrointestinal Health and Disorders
Janet M. Sasso, Ramy M. Ammar, Rumiana Tenchov, et al.
ACS Chemical Neuroscience (2023) Vol. 14, Iss. 10, pp. 1717-1763
Open Access | Times Cited: 97
Lactobacillus gallinarum-derived metabolites boost anti-PD1 efficacy in colorectal cancer by inhibiting regulatory T cells through modulating IDO1/Kyn/AHR axis
Winnie Fong, Qing Li, Fenfen Ji, et al.
Gut (2023) Vol. 72, Iss. 12, pp. 2272-2285
Open Access | Times Cited: 91
Gut Microbiota Metabolites in Major Depressive Disorder—Deep Insights into Their Pathophysiological Role and Potential Translational Applications
Miguel Á. Ortega, Miguel Ángel Alvarez‐Mon, Cielo García‐Montero, et al.
Metabolites (2022) Vol. 12, Iss. 1, pp. 50-50
Open Access | Times Cited: 86
New Insights into the Pivotal Role of the Amygdala in Inflammation-Related Depression and Anxiety Disorder
Ping Hu, Ying Lü, Bing‐Xing Pan, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 19, pp. 11076-11076
Open Access | Times Cited: 73
Kynurenine Pathway in Diabetes Mellitus—Novel Pharmacological Target?
Kamila Kozieł, Ewa M. Urbańska
Cells (2023) Vol. 12, Iss. 3, pp. 460-460
Open Access | Times Cited: 61
Causality of genetically determined metabolites and metabolic pathways on osteoarthritis: a two-sample mendelian randomization study
Yifei Gu, Qianmei Jin, Jinquan Hu, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 57
Smart Nanosensitizers for Activatable Sono‐Photodynamic Immunotherapy of Tumors by Redox‐Controlled Disassembly
Lingjun Liu, Junya Zhang, Ruibing An, et al.
Angewandte Chemie International Edition (2023) Vol. 62, Iss. 10
Closed Access | Times Cited: 50
Gut microbiota-derived indole compounds attenuate metabolic dysfunction-associated steatotic liver disease by improving fat metabolism and inflammation
Byeong Hyun Min, Shivani Devi, Goo Hyun Kwon, et al.
Gut Microbes (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 31
The therapeutic potential of dietary intervention: based on the mechanism of a tryptophan derivative-indole propionic acid on metabolic disorders
Ben Niu, Tong Pan, Yue Xiao, et al.
Critical Reviews in Food Science and Nutrition (2024), pp. 1-20
Closed Access | Times Cited: 22
Oxidative and Excitatory Neurotoxic Stresses in CRISPR/Cas9-Induced Kynurenine Aminotransferase Knockout Mice: A Novel Model for Despair-Based Depression and Post-Traumatic Stress Disorder
Ágnes Szabó, Zsolt Galla, Eleonóra Spekker, et al.
Frontiers in Bioscience-Landmark (2025) Vol. 30, Iss. 1
Open Access | Times Cited: 2
Mechanisms and Therapeutic Potential of Key Anti-inflammatory Metabiotics: Trans-Vaccenic Acid, Indole-3-Lactic Acid, Thiamine, and Butyric Acid
Mnica Cristina, Elizabeth Bautista, Renju Jose, et al.
Probiotics and Antimicrobial Proteins (2025)
Closed Access | Times Cited: 2
Interactions between gut microbiota and berberine, a necessary procedure to understand the mechanisms of berberine
Hao Cheng, Juan Liu, Yuzhu Tan, et al.
Journal of Pharmaceutical Analysis (2021) Vol. 12, Iss. 4, pp. 541-555
Open Access | Times Cited: 95
Amino Acid Trp: The Far Out Impacts of Host and Commensal Tryptophan Metabolism
Heather M. Grifka‐Walk, Brittany R. Jenkins, Douglas J. Kominsky
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 74
Interactions between Tryptophan Metabolism, the Gut Microbiome and the Immune System as Potential Drivers of Non-Alcoholic Fatty Liver Disease (NAFLD) and Metabolic Diseases
Charlotte Teunis, Max Nieuwdorp, Nordin M.J. Hanssen
Metabolites (2022) Vol. 12, Iss. 6, pp. 514-514
Open Access | Times Cited: 68
Butyrate acts through HDAC inhibition to enhance aryl hydrocarbon receptor activation by gut microbiota-derived ligands
Morgane Modoux, Nathalie Rolhion, Jéremie H. Lefèvre, et al.
Gut Microbes (2022) Vol. 14, Iss. 1
Open Access | Times Cited: 65
Tryptophan metabolism: Mechanism-oriented therapy for neurological and psychiatric disorders
Dan Li, Shuang Yu, Yu Long, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 64
A high-risk gut microbiota configuration associates with fatal hyperinflammatory immune and metabolic responses to SARS-CoV-2
Werner C. Albrich, Tarini Shankar Ghosh, Sinead Ahearn‐Ford, et al.
Gut Microbes (2022) Vol. 14, Iss. 1
Open Access | Times Cited: 55
Tryptophan metabolism and disposition in cancer biology and immunotherapy
Abdulla A.‐B. Badawy
Bioscience Reports (2022) Vol. 42, Iss. 11
Open Access | Times Cited: 42
Carotenoids Diet: Digestion, Gut Microbiota Modulation, and Inflammatory Diseases
Helena R. Rocha, Marta Coelho, Ana Gomes, et al.
Nutrients (2023) Vol. 15, Iss. 10, pp. 2265-2265
Open Access | Times Cited: 36
Page 1 - Next Page

Scroll to top